These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt, with results||2007-000728-41||A phase I/II trial testing nelfinavir, an inhibitor of Akt signaling, in combination with preoperative chemoradiotherapy in patients with locally advanced rectal cancer||not-yet-due|
|Exempt||2008-001078-34||Phase I/II study for patients with newly diagnosed glioblastoma testing nelfinavir in combination with radiotherapy and concomitant and adjuvant temozolomide||not-yet-due|
|Exempt||2009-014772-22||Chloroquine as an anti-autophagy drug in small cell lung cancer (SCLC) patients: A phase I trial to be followed by a phase II trial.||not-yet-due|
|Completed, but no date Terminated||2010-023120-24||Nitroglycerin's effect on perfusion and hypoxia in human non small cell lung cancer: proof of principle, a phase II trial||bad-data|
|Ongoing||2011-001812-80||Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer.||not-yet-due|
|Ongoing||2014-000224-17||Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer.||not-yet-due|
|Completed, but no date Terminated||2014-003873-41||Non invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial||bad-data|